4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0000950170-24-122484
Options or other derivatives
- Chief Regulatory Officer acquired 340,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schacterle Amy Chief Regulatory Officer | 2024-11-05 | Grant or award · Employee Stock Option (right to buy) | +340,000 | 340,000 | D | ||
Loading xslF345X05/ownership.xml…